Chemed Stock Net Income

CXM Stock  EUR 358.00  12.00  3.47%   
As of the 4th of March, Chemed shows the mean deviation of 1.4, and Risk Adjusted Performance of (0). Chemed technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Chemed coefficient of variation, treynor ratio, skewness, as well as the relationship between the variance and value at risk to decide if Chemed is priced correctly, providing market reflects its regular price of 358.0 per share.

Chemed Total Revenue

2.16 Billion

Chemed's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Chemed's valuation are provided below:
Gross Profit
823.2 M
Profit Margin
0.1048
Market Capitalization
4.9 B
Enterprise Value Revenue
2.3111
Revenue
2.5 B
There are over seventy-eight available fundamental signals for Chemed, which can be analyzed over time and compared to other ratios. Active traders should verify all of Chemed prevailing fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Income From Continuing Ops265.2 M230.9 M
Net Income Applicable To Common Shares287.1 M205.3 M
Net Income265.2 M230.9 M
The current Net Income From Continuing Ops is estimated to decrease to about 230.9 M. The current Net Income Applicable To Common Shares is estimated to decrease to about 205.3 M.
  
The Net Income trend for Chemed offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Chemed is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Chemed's Net Income Growth Pattern

Below is the plot of the Net Income of Chemed over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Chemed financial statement analysis. It represents the amount of money remaining after all of Chemed operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Chemed's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemed's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 265.24 M10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Chemed Net Income Regression Statistics

Arithmetic Mean185,151,394
Geometric Mean166,058,485
Coefficient Of Variation46.07
Mean Deviation78,521,430
Median205,544,000
Standard Deviation85,300,879
Sample Variance7276.2T
Range221.3M
R-Value0.86
Mean Square Error2043T
R-Squared0.74
Significance0.00001
Slope14,499,374
Total Sum of Squares116419.8T

Chemed Net Income History

2026230.9 M
2025265.2 M
2024302 M
2023272.5 M
2022249.6 M
2021268.6 M
2020319.5 M
It's important to distinguish between Chemed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Chemed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Chemed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Chemed 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Chemed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Chemed.
0.00
12/04/2025
No Change 0.00  0.0 
In 3 months and 1 day
03/04/2026
0.00
If you would invest  0.00  in Chemed on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding Chemed or generate 0.0% return on investment in Chemed over 90 days. Chemed is related to or competes with Berkshire Hathaway, Chocoladefabriken, Seaboard, NVR, WHITE MTNS, HAMMONIA Schiffsholding, and Lotus Bakeries. Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered... More

Chemed Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Chemed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Chemed upside and downside potential and time the market with a certain degree of confidence.

Chemed Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Chemed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Chemed's standard deviation. In reality, there are many statistical measures that can use Chemed historical prices to predict the future Chemed's volatility.
Hype
Prediction
LowEstimatedHigh
355.64358.02360.40
Details
Intrinsic
Valuation
LowRealHigh
355.62358.00360.38
Details
Naive
Forecast
LowNextHigh
315.43317.81320.19
Details
Earnings
Estimates (0)
LowProjected EPSHigh
4.504.524.56
Details

Chemed March 4, 2026 Technical Indicators

Chemed Backtested Returns

Chemed secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of standard deviation over the last 3 months. Chemed exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Chemed's risk adjusted performance of (0), and Mean Deviation of 1.4 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0162, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Chemed's returns are expected to increase less than the market. However, during the bear market, the loss of holding Chemed is expected to be smaller as well. At this point, Chemed has a negative expected return of -0.0058%. Please make sure to confirm Chemed's coefficient of variation, total risk alpha, skewness, as well as the relationship between the information ratio and maximum drawdown , to decide if Chemed performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.76  

Good predictability

Chemed has good predictability. Overlapping area represents the amount of predictability between Chemed time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Chemed price movement. The serial correlation of 0.76 indicates that around 76.0% of current Chemed price fluctuation can be explain by its past prices.
Correlation Coefficient0.76
Spearman Rank Test0.7
Residual Average0.0
Price Variance193.61
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Chemed Operating Income

Operating Income

309.95 Million

At this time, Chemed's Operating Income is most likely to increase significantly in the upcoming years.
Based on the recorded statements, Chemed reported net income of 265.24 M. This is 22.28% lower than that of the Health Care Providers & Services sector and 61.05% higher than that of the Health Care industry. The net income for all Germany stocks is 53.55% higher than that of the company.

Chemed Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemed's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemed could also be used in its relative valuation, which is a method of valuing Chemed by comparing valuation metrics of similar companies.
Chemed is currently under evaluation in net income category among its peers.

Chemed Fundamentals

About Chemed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chemed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Chemed Stock

Chemed financial ratios help investors to determine whether Chemed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chemed with respect to the benefits of owning Chemed security.